Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
11:20am, Tuesday, 27'th Dec 2022 Zacks Investment Research
Sector ETF report for PBE
These Will Be The Best 10 Stocks In 2023, Analysts Say
08:00am, Tuesday, 20'th Dec 2022
Phew. The S&P 500's horrible year that was 2022 is finally just about over. And analysts have picked their favorite spots.
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
03:00pm, Monday, 19'th Dec 2022 Benzinga
Upgrades
For NRG Energy Inc (NYSE:NRG), B of A Securities upgraded the previous rating of Underperform to Neutral. For the third quarter, NRG Energy had an EPS of $0.29, compared to year-ago quarter E
Wall Street Breakfast: What Moved Markets
01:03pm, Saturday, 10'th Dec 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.
Why Is Jazz (JAZZ) Up 0.1% Since Last Earnings Report?
04:30pm, Friday, 09'th Dec 2022 Zacks Investment Research
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Catalent (CTLT) Expands Facility Capabilities in Shanghai
09:47am, Tuesday, 06'th Dec 2022
Catalent's (CTLT) latest capability expansion is expected to boost its business in the clinical trials space in its Asia-Pacific Clinical Supply Services network.
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
08:02pm, Monday, 28'th Nov 2022
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
11% Of S&P 500 Stocks Suffer Their Worst Year Ever
08:00am, Monday, 28'th Nov 2022
Tesla isn't the only stock that's struggling in 2022. Nearly 60 S&P 500 stocks — or about 11% — are having their worst year ever.
Bear Of The Day: Catalent (CTLT)
08:17am, Wednesday, 16'th Nov 2022
Earnings estimates have slipped for this stock following the most recent earnings miss.
After a $100 Haircut, is Catalent an Oversold Pharma Play?
11:05am, Monday, 14'th Nov 2022
With the macro backdrop weakening for Catalent's pharmaceutical and biotech customers, fundamental concerns could outweigh what the charts suggest.
Why Shares of Catalent Fell 36% This Week
06:19pm, Friday, 04'th Nov 2022
Lowered guidance and earnings concerned investors.
Why Catalent Stock Plummeted by Nearly 25% Today
05:52pm, Tuesday, 01'st Nov 2022
Flat revenue growth, a sharp decline in profitability, and reduced guidance combined to make an awful day for the company.
Catalent, Inc. (CTLT) Q1 2023 Earnings Call Transcript
02:54pm, Tuesday, 01'st Nov 2022
Catalent, Inc. (NYSE:CTLT ) Q1 2023 Earnings Conference Call November 1, 2022 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations Alessandro Maselli - President & Chief Ex
Catalent stock paces S&P 500 losers as it suffers record selloff after earnings miss, lowered outlook
02:26pm, Tuesday, 01'st Nov 2022
Shares of Catalent Inc. CTLT, -23.31% plunged 23.4% toward a record one-day selloff, and enough to pace the S&P 500's SPX, -0.35% losers, after the contract drug manufacturing company reported fiscal
Catalent (CTLT) Q1 Earnings Lag Estimates, FY23 View Cut
02:18pm, Tuesday, 01'st Nov 2022
Catalent (CTLT) records robust first-quarter fiscal 2023 results of its Pharma and Consumer Health segment despite overall soft performance.
